# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001641172-25-026054
Filing Date
2025-08-29
Accepted
2025-08-29 17:16:00
Documents
27
Period of Report
2025-08-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8-k.htm iXBRL | 8-K | 37972
2 | EX-99.1 | ex99-1.htm | EX-99.1 | 10241
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 340985
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 362123
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 362488
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 302124
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 320143
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 338411
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 400270
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 219460
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 304462
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 383903
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 467998
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 283857
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 358330
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 276778
| Complete submission text file | 0001641172-25-026054.txt |  | 6720286

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
17 | XBRL SCHEMA FILE | envb-20250829.xsd | EX-101.SCH | 3011
18 | XBRL LABEL FILE | envb-20250829_lab.xml | EX-101.LAB | 34239
19 | XBRL PRESENTATION FILE | envb-20250829_pre.xml | EX-101.PRE | 22356
29 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3827

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 251282047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)